Sustained Benefit of TransCon PTH, a Potential Hormone Replacement Therapy for Patients with Hypoparathyroidism, at Week 58 in the PaTH Forward Trial

JOURNAL OF BONE AND MINERAL RESEARCH(2022)

Cited 0|Views18
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined